Our Portfolio

Mayo Clinic Rochester

Samer Abdul-Hay, PhD, PharmD | Minnesota, United States

Project Overview

  • Academic/Nonprofit Organization Type
  • $0 Funding Amount
  • — 12/10/10 Project Duration
  • Clinical Program
  • Status

Mayo Clinic Rochester

Samer Abdul-Hay, PhD, PharmD | Minnesota, United States

Beta-Amyloid Degradation in the CSF as a Biomarker for Alzheimer's Disease

GET IN TOUCH